Delivery Order SPE2DB20D1004-SPE2DB22FF6Q9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.63, is for the delivery of CARAFATE 1 GM TABLET 100S, a medical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Carafate 1 GM/10 ML Suspension in 420 ML bottles. The contract has a ceiling value of $3,983.93 and a completion date of July 19, 2023. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This contract award, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for the treatment of gastrointestinal conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 31, 2023. The contract does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,963.38 delivery order is for the supply of Sucralfate 1 GM/10 ML Suspension, a medication used to treat stomach and intestinal ulcers. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ52T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,688.20 firm fixed-price delivery order is for the supply of 4,563,214,896 units of Sucralfate 1 GM/10 ML Suspension, with a completion date of January 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a Delivery Order (SPE2DB23FU18T) issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,561,367,996 milliliters of Sucralfate 1 gram per 10 milliliters suspension in 420 milliliter containers, with a ceiling value of $4,093.32. The contract has a firm fixed price and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
- This federal contract award, valued at $1,728.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, ID SPE2DX15D1022|SPE2DX24FVDJL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,335.78 firm fixed-price delivery order is for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML containers, with a completion date of February 8, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,560,593,604 units of sucralfate 1 gram tablets. The contract, valued at $1,460.57, is a delivery order awarded by the Defense Logistics Agency (DLA) without any set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $1,257.66. The award is for the supply of sucralfate, a medication used to treat ulcers, with a period of performance through November 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF6Q9Delivery Order
This federal contract award is a delivery order (SPE2DB22FF6Q9) valued at $9,706.25, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a medication used to treat certain stomach and esophagus problems. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is placed against that larger IDC vehicle. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 5/17/22 |